Evidence map›Paper›PMID 33931965›Full record

ArticleClinical and translational medicine2021

Therapeutic efficiency of the APAF-1 antagonist LPT99 in a rat model of cisplatin-induced hearing loss.

Silvia Murillo-Cuesta, Adelaida M Celaya, Blanca Cervantes, Jose M Bermúdez-Muñoz, Lourdes Rodríguez-de la Rosa, Julio Contreras, Isabel Sánchez-Pérez, Isabel Varela-Nieto

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Silvia Murillo-CuestaBiomedical Research Networking Center on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain.ORCID 0000-0002-8706-4327
Adelaida M CelayaBiomedical Research Networking Center on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain.
Blanca CervantesBiomedical Research Networking Center on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain.
Jose M Bermúdez-MuñozBiomedical Research Networking Center on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain.
Lourdes Rodríguez-de la RosaBiomedical Research Networking Center on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain.
Julio ContrerasBiomedical Research Networking Center on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain.
Isabel Sánchez-PérezInstitute for Biomedical Research "Alberto Sols", Spanish National Research Council-Autonomous University of Madrid, Spain.
Isabel Varela-NietoBiomedical Research Networking Center on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain.
Instituto de Salud Carlos III · ESInstituto de Investigaciones Biomédicas Sols-Morreale · ESUniversidad Complutense de Madrid · ES

Funding

LMP POLYMORPHISMS IN B27-ASSOCIATED JUVENILE ARTHRITISK08AR002013 · NIAMS · CHILDREN'S HOSPITAL MED CTR (CINCINNATI) · PI COLBERT, ROBERT A. · 1997 to 2001
$238k
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsApoptosisApoptotic Protease-Activating Factor 1Cells, CulturedCisplatinCochleaDisease Models, AnimalHearing LossRatsApaf1 protein, ratApoptotic Protease-Activating Factor 1Cisplatin

Identifiers

PMID33931965
PMCPMC8021538
OpenAlexW3140837076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.